TuisE1WL34 • BVMF
add
Edwards Lifesciences Corp Bdr
Vorige sluiting
R$106,50
Jaarwisseling
R$85,00 - R$129,61
Markkapitalisasie
40,94Â mjd USD
Gemiddelde volume
22,00
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Inkomste | 1,35Â mjd | 8,93% |
Bedryfskoste | 697,20Â m | 11,61% |
Netto inkomste | 3,07Â mjd | 697,82% |
Netto winsgrens | 226,73 | 632,33% |
Wins per aandeel | 0,67 | 13,56% |
EBITDA | 428,80Â m | 5,88% |
Effektiewe belastingkoers | 10,10% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 4,45Â mjd | 138,54% |
Totale bates | 12,97Â mjd | 38,42% |
Totale aanspreeklikheid | 3,36Â mjd | 27,09% |
Totale ekwiteit | 9,61 mjd | — |
Uitstaande aandele | 589,80 m | — |
Prys om te bespreek | 6,58 | — |
Opbrengs op bates | 8,55% | — |
Opbrengs op kapitaal | 10,65% | — |
Kontantvloei
Netto kontantverandering
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | 3,07Â mjd | 697,82% |
Kontant van bedrywe | 351,80Â m | -14,51% |
Kontant van beleggings | 2,70Â mjd | 2Â 935,62% |
Kontant van finansiering | -976,70Â m | -581,58% |
Netto kontantverandering | 2,03Â mjd | 452,76% |
Beskikbare kontantvloei | 1,23Â mjd | 378,57% |
Meer oor
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; the Dominican Republic; Puerto Rico; and Singapore; and is building a new facility due to be completed in 2021 in Limerick, Ireland. Wikipedia
Gestig
1958
Hoofkwartier
Webwerf
Werknemers
19Â 800